UPDATE: Raymond James Downgrades NGM Biopharmaceuticals (NGM) to Outperform
Tweet Send to a Friend
(Updated - October 17, 2022 4:34 PM EDT)
Raymond James analyst Steven Seedhouse downgraded NGM Biopharmaceuticals (NASDAQ: NGM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse downgraded NGM Biopharmaceuticals (NASDAQ: NGM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
